Careers  |  Sign In  |  Register  |   Twitter

Latest in Ob/Gyn

Reuters Health • The Doctor's Channel Daily Newscast

Fenofibric acid plus a statin seen safe, effective in women with mixed dyslipidemia

NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team reports in the January 20 online issue of the American Journal of Cardiology. That conclusion comes from a post hoc analysis...

Reuters Health • The Doctor's Channel Daily Newscast

Shorter ultrasound interval boosts twin-to-twin detection

NEW YORK (Reuters Health) – An interval of no more than 14 days between ultrasonograms in monochorionic twins appears to increase detection of twin-to-twin transfusion syndrome (TTTS), researchers report in the January issue of Obstetrics and Gynecology. “The diagnosis of monochorionic twins...

Reuters Health • The Doctor's Channel Daily Newscast

Dactinomycin tops methotrexate for gestational trophoblastic neoplasia

NEW YORK (Reuters Health) – For women with low-risk gestational trophoblastic neoplasia, dactinomycin given every 2 weeks had a higher complete response rate than weekly methotrexate in a multinational, phase III trial. Despite these findings, editorialist Dr. Carol Aghajanian believes that most...